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The screening study of the hypoglycemic activity 
of herbal mixtures (presentation 3)
Diabetes mellitus is an important social and medical problem as it causes the development of dangerous complications 
leading to disability and mortality. This disease is characterized by a multi-vector pathogenesis that requires a com-
prehensive approach to the treatment. Due to the use of mixtures of medicinal plants in the treatment of diabetes it is 
possible to cover all aspects of the development of this disease and its complications. 
Aim. To study the hypoglycemic activity of herbal mixtures used in folk medicine for the prevention and treatment of 
diabetes mellitus type 2, and determine their conditional therapeutic dose.
Materials and methods. The study was performed on male albino rats weighing 180-200 g. For the preventive treat-
ment within 20 days they received orally the aqueous extracts (1:10) of the herbal mixtures studied in the doses of 
6 mL/kg/day, 9 mL/kg/day and 12 mL/kg/day and the reference drugs – the official herbal mixture “Arfazetin” in the 
dose of 9 mL/kg/day and metformin tablets in the dose of 60 mg/kg/day. The study of hypoglycemic properties and 
determination of the conditional therapeutic dose of the mixtures studied were performed using glucose loading tests 
(oral glucose tolerance test – OGTT and intraperitoneal glucose tolerance test– IPGTT). All experiments were performed 
in accordance with general ethical principles with the recommendations of the EEC Council Directive 2010/63/EU 
about the protection of animals used for scientific purposes.
Results and discussion. The results of the study showed that the 20-day preventive treatment with the herbal mix-
tures reduced alimentary hyperglycemia 30 minutes after OGTT and regulated carbohydrate tolerance disorders by 
reducing hyperglycemia 15 minutes after IPGTT. The herbal mixture No. 13 in the dose of 12 mL/kg/day showed the 
highest hypoglycemic activity, which was almost similar with the reference drug – metformin tablets, but exceeded 
the official herbal mixture “Arfazetin” by its efficiency. In addition, the dose-dependence of the effectiveness of all five 
herbal mixtures studied was determined.
Conclusions. For the first time, the screening study of the hypoglycemic activity of herbal mixtures used in folk medi-
cine for the prevention and treatment of diabetes mellitus type 2 has been conducted. It has been determined that the 
herbal mixture No. 13 containing Cichorii radices, Elymi repens rhizomata, Helichrysi arenarii flores, Rosae fructus, May-
dis style cum stigmatis shows the highest effectiveness by the ability to reduce alimentary hyperglycemia during OGTT 
and reduce impaired carbohydrate tolerance during IPGTT. Its conditional therapeutic dose, which is 12 mL/kg/day, 
has been determined.
Key words: herbal mixtures; hypoglycemic activity; diabetes mellitus; oral glucose tolerance test; intraperitoneal glucose 
tolerance test
А. О. Савич, С. М. Марчишин, I. І. Мілян
Тернопільський національний медичний університет імені І. Я. Горбачевського МОЗ України































А. А. Савич, С. М. Марчишин, И. И. Милян
Тернопольский национальный медицинский университет им. И. Я. Горбачевского МЗ Украины
































Diabetes mellitus is a global social problem in  the  field  of  healthcare  due  to  a  rapid 
spread of this disease and the development of se-




Federation (2019), the number of patients is pro-
jected to increase to 642 million by 2040 [2]. 
An important problem of pharmacovigilance is 
that the existing pharmacotherapy can effectively 
reduce hyperglycemia, but it is not always able to 
stabilize fluctuations in glycemic values during the 
day and maintain it at an optimal level. This leads 
to the formation of a cascade of pathological pro-
cesses – excessive glycation and inactivation of the 
body’s antioxidant defense system, triggering the 
processes of free radical oxidation of lipids and, 
consequently, the development of oxidative stress, 
which leads to the development and progression of 
diabetic angiopathies [1, 3, 4]. 
Therefore, the optimization of pharmacothera-
py, search and study of new drugs with the hypo-
glycemic activity for the prevention and treatment 
of this disease and its dangerous complications is a 
topical issue of pharmacy and medicine.
One of the areas is phytotherapy since it has a 
number of advantages over traditional therapy with 
using oral synthetic agents, namely, it is low-toxic, has 
a mild pharmacological effect and can be used for 
long periods without significant side effects, is well 
combined with synthetic drugs, has a complex ac-
tivity in a number of biologically active compounds 
[5, 6]. Particular attention deserve the combinations 
of different medicinal plants as these herbal mix-
tures have more biologically active substances that 
will influence on all links of the pathogenetic me- 
chanism of diabetes mellitus development and its 
complications [7-9]. In addition, the pharmaceutical 
market of Ukraine is represented mainly by syn-
thetic antidiabetic drugs, which account for over 
92 % of all oral antidiabetic drugs. Today there are 
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two antidiabetic herbal mixtures in Ukraine – the 
herbal mixture “Arfazetin” containing Vaccinii myr-
tilli cormus, Phaseoli valvae fructum, Eleutherococci 
senticosi rhizomata et radices, Rosae fructus, Equi- 
seti arvensis herba, Hyperici herba, Matricariae flores 
and the herbal mixture “Sadifit” containing Helian- 
thi tubera, Steviae folia, Vaccini myrtilli cormus, Pha- 
seoli valvae fructum, Thea chinensis, Menthae piperi- 
tae folia.
However, Vaccinii myrtilli cormus, Eleutherococci 
senticosi rhizomata et radices and Hyperici herba 
are potent plants that can be dangerous with the 
prolonged use. In addition, Eleutherococci senticosi 
rhizomata et radices has a tonic effect and is con-
traindicated in coronary heart disease, heart failure 
and hypertension, which are often complications of 
diabetes.
Thus, the aim of our research was to study the 
hypoglycemic activity of herbal mixtures used in 
folk medicine for the prevention and treatment of 




The herbal raw material harvested in June to 
August 2019 in the Ternopil region (Ukraine) was 
used. After collecting the raw material was dried, 
crushed and standardized according to the general 
GACP requirements [11]. The plants were identified  
by the Department of Pharmacognosy with Medical 
Botany, I. Horbachevsky Ternopil National Medical 
University, Ternopil, Ukraine. The voucher specimens 
of the herbal raw materials were deposited in the 
Departmental Herbarium for future record.
For the study, five different herbal mixtures used  
in folk medicine for the prevention and treatment of 
diabetes mellitus type 2 in Ukraine were applied [10]. 
The composition of the mixtures is given in Tab. 1.
The samples of the herbal raw material were 
powdered by a laboratory mill. Then 10 g of each 
powdered herbal mixture was put into a 100 mL 
conical flask, and 120 mL of distilled water was 
added to each. The aqueous extracts were obtained 
by heating on the boiling water bath for 30 min. 
The extracts were filtered using Whatmann filter 
paper  No.  1.  Then  the  filtrates  were  evaporated 
by a rotary evaporator and lyophilized to dryness. 
The lyophilized powders of each herbal mixture were 
stored at 4 °C for further use. 
The aqueous extract of the reference drug – the 
official herbal mixture “Arfazetin” was prepared us-
ing 5 g of a dry raw material and 110 mL of dis-
tilled water (as indicated in the instructions for use) 
under the same conditions.
To prepare the metformin suspension, metform-






The study was performed on male albino rats 
weighing between 180-200 g bred in the vivarium 
of the Central Research Laboratory at I. Horbachev- 
sky Ternopil National Medical University where they 
were kept under appropriate conditions (at a con-
stant room temperature of 22 ± 1 °C, 40-70 % hu-
midity conditions and a 12-hour light/dark cycle). 
Throughout the experimental period the animals 
received a standard rat diet and water ad libitum. 
The animals were treated in accordance with the in-
ternationally accepted standard ethical guidelines 
for laboratory animal use and care as described in 
the European Community Guidelines [12]. All pro-
tocols for animals experiment were approved by the 
animal ethical committee of I.Horbachevsky Terno- 
pil National Medical University.
Table 1
The composition of the herbal mixtures
Herbal 
mixtures Medicinal plants
The amount of 




Maydis style cum stigmatis
Elymi repens rhizomata 
Leonuri cardiacae herba 
Betulae verrucosae folia  











Helianthi tuberosi  tuber
Callunae herba 
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The screening study of the hypoglycemic activ-
ity of herbal mixtures and determination of their 
conditionally therapeutic dose was performed in 
intact normoglycemic rats. Animals were random-
ly divided into eight groups of eight animals (n=8) 
each and received different preventive treatment 
once daily for 20 days. Group I (control) received 
distilled water (12 mL/kg/day) per os (p.o.), group II 
(HM “Arfazetin”) – an aqueous extract of the official  
herbal mixture “Arfazetin” (9 mL/kg/day, p.o.) [13], 
group III (MET) – a suspension of metformin 
(60 mg/kg/day, p.o.) [14], group IV-VIII (HM) – aqueous  
extracts of the herbal mixtures No. 11-15 in the doses 
6 mL/kg/day, 9 mL/kg/day and 12 mL/kg/day, p.o. 
The last oral administration of the products stud-
ied was 2 hours before the glucose load tests. 
Fasting blood glucose (basal glycemia) was mea- 
sured in tail blood samples after a 6-hour fast on the 
20th day of the experiment using a glucose analy- 
zer (Accuk-Check glucometer, Germany). The oral 
glucose tolerance test (OGTT) was performed after 
measuring basal glycemia by administering glucose 
solution (3 g/kg, p. o). Blood glucose levels were 
determined in 0, 30, 60 and 120 minutes after glu-
cose loading [15].
Measurements of the intraperitoneal glucose to- 
lerance test (IPGTT) were performed on the 21st day 
of the experiment after overnight fasting (16-18 hours) 
by intraperitoneal administration of glucose solu-
tion (2 g/kg, i. p.) to rats in the morning. The level 
of glucose in the blood obtained from the tail vein 
of animals was determined before the introduction 
of glucose and in 15, 45 and 60 minutes after using 
a glucose analyzer [15].
The  values  were  expressed  as  mean  ±  SEM.  
The data were analyzed using GraphPad Prism soft- 
ware, version 5.03. The results were compared us-
ing the ANOVA-One-Way test followed by Mann-
Whitney U test. The difference was considered to be 
statistically significant at p<0.05. The value of the 
integrated glycemic index of the area under glycemic 




fect of the herbal mixtures and the reference drugs 
on basal glycemia and on glycemia after carbohy-
drate loading by OGTT after 20 days of the preven-
tive treatment was studied. This test allows simu-
lating alimentary hyperglycemia that occurs after 
eating. The hypoglycemic activity of the herbal mix- 
tures and reference drugs was manifested by their 
ability to reduce blood glucose levels in 30 minu- 
tes of the test during its maximum increase in re-
sponse to oral carbohydrate load.
The results of the study showed that the 20-day 
preventive  treatment  by  all  five  herbal  mixtures  
(No. 11-15) in the doses of 6 mL/kg/day, 9 mL/kg/day 
and 12 mL/kg/day significantly (p<0.05) reduced 
glycemia in 30 minutes after OGTT compared to the 
control group. However, the herbal mixture No. 13 
in the dose of 12 mL/kg/day showed the best re-
sults of the hypoglycemic activity in 30 minutes af-
ter the test, and it reduced blood glucose levels by 
45 %, relative to the control group. Metformin tab-
lets demonstrated a similar result in efficacy as they 
reduced alimentary hyperglycemia by 46 % rela-
tive to the control group of animals in 30 minutes. 
The official herbal mixtures “Arfazetin” was inferior in 
efficiency to the herbal mixture No. 13 in the dose 
of 12 mL/kg/day and reduced glycemia by 32 % 
relative to the control group in 30 minutes after the 
test (Tab. 2).
During the determination of the integrated gly-
cemic index based on the results of OGTT it was 
found that the area under glycemic curve (AUCglu) 
of the herbal mixture No. 13 (12 mL/kg/day) was 
262.2 mmol/L min. Regarding the results of the refe- 
rence drugs the AUCglu of metformin (60 mg/kg/day) 
was lower and amounted to 256.8 mmol/L min, and 
that of the herbal mixture “Arfezetin” (9 mL/kg/day)  
was higher and amounted to 322.8 mmol/L min.
At the second stage of the screening study the 
ability of the herbal mixtures No. 11-15 and the re- 
ference drugs to improve carbohydrate tolerance 
was determined using IPGTT. The hypoglycemic ef-
fect of the herbal mixtures and the reference drugs 
was assessed by their ability to reduce hypergly-
cemia in 15 minutes after IPGTT during the maxi-
mum rise of blood glucose in animals in response 
to intraperitoneal carbohydrate load.
During the study, a significant (p<0.05) increase 
in blood glucose levels was observed in animals 
from the control group in 15 minutes of the test 
(hyperglycemic peak), exceeding the initial data by 
2.0 times. The best ability to reduce the hypergly-
cemic peak of IPGTT showed the herbal mixture 
No. 13 (12 mL/kg/day); the blood glucose level 
was lower by 26 % relative to the control group. 
Metformin tablets showed a similar effect and re-
duced hyperglycemia in 15 minutes of the test by 
27 % relative to the control group, and the official 
herbal mixture “Arfazetin” was slightly inferior to  
the effectiveness of the herbal mixture No. 13 in the 
dose of 12 mL/kg/day and reduced hyperglycemia 
by 21 %. By the end of the experiment in 60 minu- 
tes after IPGTT the blood glucose level returned to 
baseline in all groups of animals (Tab. 3).
The results of the screening study of the herbal 
mixtures No. 11-15 used in folk medicine for the 
prevention and treatment of diabetes mellitus type 2 
using OGTT and IPGTT indicate a dose-dependent 
hypoglycemic activity. The best hypoglycemic ef-
fect of the objects studied was shown in the dose 
of 12 mL/kg/day.
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Table 2
The hypoglycemic effect of the herbal mixtures compared to the official herbal mixture 
“Arfazetin” and metformin tablets by oral glucose tolerance test in 20 days of the preventive 
treatment in normoglycemic rats
Group of animals
Glucose level, mmol/L
0 min 30 min 60 min 120 min
Series 3 of the experiments
Control 4.17±0.07 7.89±0.09 7.62±0.12 5.85±0.13
HM “Arfazetin”, 9 mL/kg 4.08±0.08 5.38±0.11* 5.33±0.15* 4.92±0.14*
MET, 60 mg/kg 3.91±0.16 4.28±0.17*/** 4.17±0.18*/** 4.02±0.14*/**
HM No. 11, 6 mL/kg 4.07±0.18 5.66±0.17* 5.52±0.15* 5.34±0.14*
HM No. 11, 9 mL/kg 3.92±0.16 5.58±0.11* 5.39±0.13* 5.22±0.18*
HM No. 11, 12 mL/kg 4.18±0.11 5.72±0.17* 5.55±0.16* 5.31±0.19*
HM No. 12, 6 mL/kg 4.02±0.17 5.65±0.18* 5.39±0.17* 5.24±0.18*
HM No. 12, 9 mL/kg 4.07±0.17 5.63±0.18* 5.47±0.17* 5.29±0.19*
HM No. 12, 12 mL/kg 4.05±0.15 5.52±0.12* 5.33±0.15* 5.25±0.14*
HM No. 13, 6 mL/kg 3.96±0.11 5.61±0.18* 5.43±0.18* 5.20±0.17*
HM No. 13, 9 mL/kg 4.01±0.16 5.48±0.18* 5.31±0.18* 5.11±0.19*
HM No. 13, 12 mL/kg 3.92±0.17 4.37±0.19*/** 4.23±0.15*/** 4.04±0.14*
HM No. 14, 6 mL/kg 4.07±0.11 5.69±0.12* 5.53±0.18* 5.31±0.10*
HM No. 14, 9 mL/kg 4.02±0.15 5.66±0.17* 5.43±0.15* 5.19±0.19*
HM No. 14, 12 mL/kg 4.04±0.16 5.68±0.17* 5.38±0.11* 5.20±0.18*
HM No. 15, 6 mL/kg 4.11±0.08 5.59±0.11* 5.42±0.16* 5.31±0.18*
HM No. 15, 9 mL/kg 4.03±0.17 5.49±0.17* 5.32±0.18* 5.21±0.12*
HM No. 15, 12 mL/kg 4.11±0.17 5.42±0.18* 5.38±0.17* 5.19±0.17*
Note. Values are expressed as mean ± SEM of 8 rats; * p<0.05 with respect to the control group; ** p<0.05 with respect  
to the herbal mixture “Arfazetin”.
Table 3
The hypoglycemic effect of the herbal mixtures compared to the official herbal mixture 
“Arfazetin” and tablets metformin by intraperitoneal glucose tolerance test in 20 days  
of the preventive treatment in normoglycemic rats
Group of animals
Glucose level, mmol/L
0 min 15 min 45 min 60 min
Series 3 of the experiments
Control 4.21±0.11 8.62±0.17* 5.23±0.18 4.42±0.11
HM “Arfazetin”, 9 mL/kg 4.19±0.18 6.82±0.19* 5.01±0.17 4.43±0.15
MET, 60 mg/kg 4.14±0.19 6.32±0.17*/** 4.92±0.18 4.21±0.13
HM No. 11, 6 mL/kg 4.16±0.16 7.44±0.17* 5.31±0.13 4.28±0.12
HM No. 11, 9 mL/kg 4.18±0.15 7.31±0.18* 5.27±0.16 4.27±0.17
HM No. 11, 12 mL/kg 4.18±0.16 7.21±0.16* 5.09±0.17 4.29±0.13
HM No. 12, 6 mL/kg 4.19±0.17 7.41±0.18* 5.38±0.16 4.31±0.17
HM No. 12, 9 mL/kg 4.22±0.18 7.32±0.16* 5.28±0.19 4.29±0.22
HM No. 12, 12 mL/kg 4.20±0.18 7.21±0.18* 5.11±0.18 4.32±0.21
HM No. 13, 6 mL/kg 4.09±0.17 7.23±0.19* 5.15±0.13 4.21±0.18
HM No. 13, 9 mL/kg 4.17±0.16 7.09±0.17* 5.09±0.12 4.22±0.21
HM No. 13, 12 mL/kg 4.16±0.18 6.38±0.18*/** 4.94±0.17* 4.21±0.12
HM No. 14, 6 mL/kg 4.19±0.16 7.37±0.16* 5.32±0.19 4.28±0.16
HM No. 14, 9 mL/kg 4.18±0.16 7.29±0.13* 5.29±0.13 4.27±0.12
HM No. 14, 12 mL/kg 4.16±0.12 7.09±0.16* 5.17±0.16 4.28±0.16
HM No. 15, 6 mL/kg 4.18±0.17 7.29±0.13* 5.22±0.13 4.25±0.11
HM No. 15, 9 mL/kg 4.22±0.17 7.21±0.15* 5.06±0.17 4.29±0.27
HM No. 15, 12 mL/kg 4.20±0.12 7.16±0.19* 5.04±0.13 4.29±0.17
Note. Values are expressed as mean ± SEM of 8 rats; * p<0.05 with respect to the control group; ** p<0.05 with respect  
to the herbal mixture “Arfazetin”.
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The study using glucose load tests showed that 
the herbal mixtures No. 11, No. 12, No. 14 and No. 15 
in the doses of 6 mL/kg/day, 9 mL/kg/day and 
12 mL/kg/day exhibited the hypoglycemic activity, 
but it was slightly lower compared to the herbal mix-
ture No. 13 (12 mL/kg/day) and the reference drugs – 
the official herbal mixture “Arfazetin” (9 mL/kg/day)  
and metformin tablets (60 mg/kg/day) (Tab. 2, 3).
The hypoglycemic activity of the herbal mixtures 
studied is quite predictable since they include the 
medicinal plant raw material containing biologi-
cally active substances with the proven hypoglyce-
mic action. The main groups of biologically active 
substances that can lower blood glucose are poly-
saccharides, especially inulin that has the ability to 
increase glucagon-like peptide-1 (GLP-1), which in- 
creases insulin secretion, inhibits glucagon secretion, 
causes proliferation and neogenesis of β-cells and 
increases the response of β-cells to glucose [16, 17]. 
The herbal mixtures under research contain the 
herbal raw material that are rich in carbohydrates, 
such as Cichorii radices (the herbal mixtures No. 13 
and No. 14), Taraxaci radices (the herbal mixture 
No. 15), Elymi repens rhizomata (the herbal mixtu- 
res No. 11, No. 13 and No. 14), Helianthi tuberosi 
tuber (the herbal mixtures No. 11 and No. 12), Plan- 
taginas majoris folia (the herbal mixture No. 11), 
Althaeae radices (the herbal mixture No. 12).
In addition, medicinal plants that are part of the 
herbal mixtures studied contain polyphenolic com- 
pounds that exhibit the antidiabetic activity by dif-
ferent mechanism of actions, including stimulation 
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HM No. 15, 12 mL/kg
AUC , mmol/L minglu
Fig.  The hypoglycemic effect of the herbal mixtures compared to the official herbal mixture “Arfazetin” and metformin 
tablets by OGTT in 20 days of the preventive treatment of normoglycemic rats, mean ± SEM, n=8
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intensification of glucose uptake, delay of carbohy-
drate digestion and glucose absorption, inhibition 
of protein glycation and insulin fibrillation [18-20].  
No less important is their antioxidant activity in the 
treatment and prevention of diabetes and its com-
plications since they can include suppression of for- 
ming reactive oxygen species (ROS) either by inhi-
bition of enzymes or by chelating trace elements in-
volved in free radical generation; scavenging ROS; 
inhibition of the enzymes involved in ROS genera-
tion – microsomal monooxygenase, glutathione 
S-transferase, mitochondrial succinoxidase, nicotin- 
amide adenine dinucleotide phosphate (NADH) oxi- 
dase, and so forth [20-22]. The medicinal plant raw 
material containing phenolic compounds are Leo- 
nuri cardiacae herba (the herbal mixture No. 11), 
Betulae verrucosae folia (the herbal mixture No. 11), 
Origani herba (the herbal mixture No. 12), Callunae 
herba (the herbal mixture No. 12), Maydis style cum 
stigmatis (the herbal mixtures No. 11 and No. 13), 
Polygoni avicularis herba (the herbal mixture No. 12), 
Helichrysi arenarii flores (the herbal mixture No. 13), 
Rosae fructus (the herbal mixtures No. 13 and No. 14), 
Galegae herba (the herbal mixture No. 15), Crataegi 
fructus (the herbal mixtures No. 11, No. 12 and No. 14), 
Myrtilli fructus (the herbal mixture No. 14) and Myr- 
tilli folia (the herbal mixture No. 15).
Thus, the screening study of herbal mixtures 
No. 11-15 shows their hypoglycemic activity in OGTT, 
IPGTT and confirms the effectiveness of their use 
in folk medicine for the prevention and treatment 
of diabetes mellitus type 2.
CONCLUSIONS
1. For the first time, the screening study of the 
hypoglycemic activity of herbal mixtures No. 11-15 
used in folk medicine for the prevention and treat-
ment of diabetes mellitus type 2 has been conducted. 
2. It has been determined that the herbal mix-
ture No. 13 containing Cichorii radices, Elymi repens 
rhizomata, Helichrysi arenarii flores, Rosae fructus, 
Maydis style cum stigmatis shows the highest effec-
tiveness by the ability to reduce alimentary hyper-
glycemia during OGTT and reduce impaired carbo- 
hydrate tolerance during IPGTT. Its conditional 
therapeutic dose, which is 12 mL/kg/day, has been 
determined.
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